Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial

Published:2018-03-26 Issue:10 Volume:124 Page:2169-2173
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gold Kathryn A.¹^ORCID,Kies Merrill S.²,William William N.²,Johnson Faye M.²,Lee J. Jack³,Glisson Bonnie S.²

Affiliation:

1. Division of Hematology and Oncology, Moores Cancer Center; University of California-San Diego; La Jolla California

2. Department of Thoracic/Head and Neck Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

National Cancer Institute

Astellas Pharma

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference22 articles.

1. Incidence estimate of nonmelanoma skin cancer in the United States, 2006;Rogers;Arch Dermatol,2010

2. Cutaneous squamous-cell carcinoma;Alam;N Engl J Med,2001

3. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012;Karia;J Am Acad Dermatol,2013

4. Mortality risk from squamous cell skin cancer;Clayman;J Clin Oncol,2005

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review;Cancers;2024-08-21

2. Plattenepithelkarzinom der Haut;hautnah;2024-07-09

3. Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances;Current Oncology Reports;2024-07-02

4. Real-World Treatment Patterns and Outcomes of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma Treated in US Oncology Practices;Cancer Management and Research;2024-07

5. Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities;International Journal of Molecular Sciences;2024-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3